A single arm open label non-comparative Phase-I study to evaluate safety, reactogenicity and immunogenicity of single intramuscular dose of 14-valent pneumococcal polysaccharide conjugate vaccine (without preservative) of Biological E. Limited in 18-45 year-old healthy adults. - None

Trial Profile

A single arm open label non-comparative Phase-I study to evaluate safety, reactogenicity and immunogenicity of single intramuscular dose of 14-valent pneumococcal polysaccharide conjugate vaccine (without preservative) of Biological E. Limited in 18-45 year-old healthy adults. - None

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 14 Dec 2017

At a glance

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top